EU, method C preference [Two-Stage / GS Designs]

posted by ElMaestro  – Denmark, 2019-10-11 10:25 (789 d 01:48 ago) – Posting: # 20683
Views: 3,946

Hi all,

I remember having heard EU regulators mention preference for method C out of consideration for the type I error. But I can't seem to find a presentation from anyone saying so. Do you know, do one of you experts have a link or a presentation by a regulator where this was stated?

Many thanks.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Wednesday 11:13 CET (Europe/Vienna)

There is no adequate defense, except stupidity,
against the impact of a new idea.    Percy Williams Bridgman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5